Search

everythinglearnresearchcommunity

for

Search:↓

The study found that a specific genetic variation in the TNFα gene is significantly linked to Alopecia Areata in the Jordanian Arab population.

The conclusion is that having both Frontal Fibrosing Alopecia and Discoid Lupus Erythematosus may suggest a shared immune response in certain people, and a mix of antimalarial drugs and 5-alfa-reductase inhibitors is recommended for treatment.

ICAM-1 helps regulate hair growth cycles and skin remodeling.

Alopecia areata involves specific immune cells, offering potential treatment targets.

Patients with RASopathies are at risk for autoimmune disorders and should be routinely screened.

Thyroid and skin autoimmune diseases share genetic and immune links, affecting both tissues.

Understanding how acne develops in different diseases could lead to new treatments.

Immunological treatment improved both neuropathy and alopecia.

Cortisone tapering may help improve severe myasthenia gravis and alopecia areata after thymectomy.

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.

Oral lichen planus is a chronic disease causing mouth discomfort and sometimes needs immunosuppressive treatment.

New digital tools are improving the diagnosis and understanding of irreversible hair loss conditions.

Alopecia areata in elderly people is usually mild and responds well to treatment.

A man developed myasthenia gravis after alopecia areata, and treatment improved his symptoms and stopped hair loss.

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

Hyperadrenocorticism in ferrets is linked to neutering and indoor housing, and is best treated with surgery and a deslorelin implant.

Histone modification is key in treating chronic inflammatory skin diseases.

New understanding of the causes of primary cicatricial alopecia has led to better diagnosis and potential new treatments.

Impaired skin barrier function worsens acne.

Gut microbiota changes might play a role in alopecia areata, and microbiome-targeted treatments show promise.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

Age-related immune changes worsen Parkinson's disease, suggesting new treatment strategies.

Pregnancy causes skin changes like darkening, hair thickening, nail changes, and increased risk of skin growths, most of which usually resolve after birth.

The article suggests that targeting specific immune pathways could help control and treat the skin disease hidradenitis suppurativa.

The S250C variant in a gene may cause autoimmunity and immunodeficiency by impairing protein function.

Restoring hair bulb immune privilege is crucial for managing alopecia areata.

Anti-acne medications may work by reducing the activity of a protein involved in acne development.

Type I interferons play a key role in the development of various skin diseases.

Vogt-Koyanagi-Harada disease can develop during interferon therapy for chronic hepatitis C.

The conditions alopecia areata, primary sclerosing cholangitis, and ulcerative colitis may be linked by shared autoimmune and cell death mechanisms.